Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
出版年份 2017 全文链接
标题
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
作者
关键词
-
出版物
LEUKEMIA
Volume 32, Issue 1, Pages 102-110
出版商
Springer Nature
发表日期
2017-06-06
DOI
10.1038/leu.2017.179
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Next-generation multiple myeloma treatment: a pharmacoeconomic perspective
- (2016) S. V. Rajkumar et al. BLOOD
- Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group
- (2016) P. Sonneveld et al. BLOOD
- Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics
- (2016) Najoua Lalaoui et al. CANCER CELL
- Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study
- (2016) Tasnim Chagtai et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Philippe Moreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
- (2015) Brian A. Walker et al. JOURNAL OF CLINICAL ONCOLOGY
- β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis
- (2015) Lucas K Smith et al. NATURE MEDICINE
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
- (2015) Brian A. Walker et al. Nature Communications
- Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB
- (2015) Yulia N. Demchenko et al. Oncotarget
- Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease
- (2014) J. R. Sawyer et al. BLOOD
- Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
- (2014) Laura Tornatore et al. CANCER CELL
- A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma
- (2014) Eileen M. Boyle et al. GENES CHROMOSOMES & CANCER
- An overview of the progress in the treatment of multiple myeloma
- (2014) Robert A Kyle et al. Expert Review of Hematology
- Long-term Follow-up of MRC Myeloma IX Trial: Survival Outcomes with Bisphosphonate and Thalidomide Treatment
- (2013) G. J. Morgan et al. CLINICAL CANCER RESEARCH
- Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma
- (2013) S. Van Wier et al. HAEMATOLOGICA
- The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
- (2013) C Touzeau et al. LEUKEMIA
- A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR
- (2013) M F Kaiser et al. LEUKEMIA
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- A20 and CYLD Do Not Share Significant Overlapping Functions during B Cell Development and Activation
- (2012) Yuanyuan Chu et al. JOURNAL OF IMMUNOLOGY
- The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy
- (2011) Kevin D. Boyd et al. GENES CHROMOSOMES & CANCER
- Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
- (2011) Gareth J Morgan et al. LANCET ONCOLOGY
- A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
- (2011) K D Boyd et al. LEUKEMIA
- A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
- (2010) B. A. Walker et al. BLOOD
- Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome
- (2010) N. J. Dickens et al. CLINICAL CANCER RESEARCH
- Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia
- (2010) C. J. Schwab et al. GENES CHROMOSOMES & CANCER
- The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance
- (2010) F. M. Ross et al. HAEMATOLOGICA
- Prognostic Significance of Copy-Number Alterations in Multiple Myeloma
- (2009) Hervé Avet-Loiseau et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now